This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donati, D.
Right arrow Articles by Jacobson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donati, D.
Right arrow Articles by Jacobson, S.

 Previous Article  |  Next Article 

Journal of Virology, August 2005, p. 9439-9448, Vol. 79, No. 15
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.15.9439-9448.2005

Variant-Specific Tropism of Human Herpesvirus 6 in Human Astrocytes

Donatella Donati ,1,{dagger},{ddagger} Elena Martinelli,1,{dagger} Riccardo Cassiani-Ingoni,1 Jenny Ahlqvist,1,§ Jean Hou,2 Eugene O. Major,2 and Steve Jacobson1*

Viral Immunology Section,1 Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland2

Received 4 February 2005/ Accepted 20 April 2005

Though first described as a lymphotropic virus, human herpesvirus 6 (HHV-6) is highly neuropathogenic. Two viral variants are known: HHV-6A and HHV-6B. Both variants can infect glial cells and have been differentially associated with central nervous system diseases, suggesting an HHV-6 variant-specific tropism for glial cell subtypes. We have performed infections with both viral variants in human progenitor-derived astrocytes (HPDA) and monitored infected cell cultures for cytopathic effect (CPE), intra- and extracellular viral DNA load, the presence of viral particles by electronic microscopy, mRNA transcription, and viral protein expression. HHV-6A established a productive infection with CPE, visible intracellular virions, and high virus DNA loads. HHV-6B-infected HPDA showed no morphological changes, intracellular viral particles, and decreasing intra- and extracellular viral DNA over time. After long-term passage, HHV-6B-infected HPDA had stable but low levels of intracellular viral DNA load with no detectable viral mRNA. Our results demonstrate that HHV-6A and HHV-6B have differential tropisms and patterns of infection for HPDA in vitro, where HHV-6A results in a productive lytic infection. In contrast, HHV-6B was associated with a nonproductive infection. These findings suggest that HHV-6 variants might be responsible for specific infection patterns in glial cells in vivo. Astrocytes may be an important reservoir for this virus in which differential tropism of HHV-6A and HHV-6B may be associated with different disease outcomes.


* Corresponding author. Mailing address: Bldg. 10, Room 5N214, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 496-0519. Fax: (301) 402-0373. E-mail: jacobsons{at}ninds.nih.gov.

{dagger} D.D. and E.M. equally contributed to this work.

{ddagger} Present address: Struttura Complessa di Microbiologia e Virologia, Azienda Ospedaliera Universitaria Senese, Siena, Italia.

§ Present address: Division of Neurology, Neurotec Department, Karolinska Institute at Karolinska University Hospital in Huddinge, Stockholm, Sweden.


Journal of Virology, August 2005, p. 9439-9448, Vol. 79, No. 15
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.15.9439-9448.2005




This article has been cited by other articles:

  • Oster, B., Kofod-Olsen, E., Bundgaard, B., Hollsberg, P. (2008). Restriction of human herpesvirus 6B replication by p53. J. Gen. Virol. 89: 1106-1113 [Abstract] [Full Text]  
  • Kofod-Olsen, E., Ross-Hansen, K., Mikkelsen, J. G., Hollsberg, P. (2008). Human herpesvirus 6B U19 protein is a PML-regulated transcriptional activator that localizes to nuclear foci in a PML-independent manner. J. Gen. Virol. 89: 106-116 [Abstract] [Full Text]